I currently take medication for acromegaly

If you currently take medication for acromegaly but you're interested in trying another medication, talk to your healthcare professional.

Perhaps your medication isn't working as well as you would have hoped. Maybe you're looking for a medication that's easier to administer and take. Or, possibly you're just looking for a treatment that's more convenient.

An easy-to-take, convenient alternative to other treatments: Somatuline^®Depot (lanreotide) Injection (lanreotide) Injection

Ask your healthcare professional about Somatuline^® Depot (lanreotide) Injection. It's FDA-approved as an effective, safe, and generally well-tolerated medical treatment for acromegaly. And it's different from other treatments.

Somatuline^® Depot (lanreotide) Injection comes in a single, ready-to-use, prefilled syringe that is injected in a simple, easy procedure.

Learn more about Somatuline^® Depot (lanreotide) Injection

Find out why it's more convenient than other treatment options.

Read about who should take Somatuline^® Depot (lanreotide) Injection

See if Somatuline^® Depot (lanreotide) Injection is the right treatment option for you.

Find out how Somatuline^® Depot (lanreotide) Injection works

See how Somatuline^® Depot (lanreotide) Injection works to help your body control acromegaly.

IMPORTANT SAFETY INFORMATION

Somatuline^®Depot (lanreotide) Injection (lanreotide) Injection is a somatostatin analog indicated for the long-term treatment of patients with acromegaly who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy.

Lanreotide may reduce gallbladder motility and lead to gallstone formation. Periodic monitoring may be needed. Patients treated with Somatuline^®Depot (lanreotide) Injection may experience hypoglycemia or hyperglycemia. Glucose levels monitoring is recommended and antidiabetic treatment adjusted accordingly. Lanreotide may lead to a decrease in heart rate. Use with caution in at-risk patients.

Patients with moderate and severe renal impairment or moderate and severe hepatic impairment should begin treatment with Somatuline^®Depot (lanreotide) Injection 60mg.

There are no adequate and well controlled studies in pregnant women. Because animal reproduction studies are no always predictive of human responses, Somatuline^®Depot (lanreotide) Injection should be used during pregnancy only if the potential benefit justifies risk to the fetus. A decision should be made whether to discontinue nursing or discontinue the drug taking into account the importance of the drug to the mother.

Somatuline^®Depot (lanreotide) Injection may decrease the bioavailability of cyclosporine. Cyclosporine dose may need to be adjusted to maintain levels.

Patients receiving beta-blockers, calcium channel blockers, or other drugs that affect heart rate may need dose adjustments. Somatuline^®Depot (lanreotide) Injection may reduce the intestinal absorption of co-administered drugs. Caution should be used.

The most common adverse reactions (incidence >5%) are diarrhea, cholelithiasis, abdominal pain, nausea, injection site reaction, flatulence, arthralgia, and loose stools.

Please see Full Prescribing Information for additional important information.

Somatuline^®Depot (lanreotide) Injection IS MARKETED BY TERCICA, INC. AND MANUFACTURED BY IPSEN PHARMA BIOTECH (SIGNES, FRANCE).

View our injection video

An easy-to-take, convenient alternative to other treatments: Somatuline®Depot (lanreotide) Injection (lanreotide) Injection

Learn more about Somatuline® Depot (lanreotide) Injection

Read about who should take Somatuline® Depot (lanreotide) Injection

Find out how Somatuline® Depot (lanreotide) Injection works

IMPORTANT SAFETY INFORMATION

An easy-to-take, convenient alternative to other treatments: Somatuline^®Depot (lanreotide) Injection (lanreotide) Injection

Learn more about Somatuline^® Depot (lanreotide) Injection

Read about who should take Somatuline^® Depot (lanreotide) Injection

Find out how Somatuline^® Depot (lanreotide) Injection works